多囊卵巢
药丸
医学
妇科
人口
卵巢
糖尿病
胰岛素抵抗
生理学
内分泌学
药理学
环境卫生
作者
S. Nader,Evanthia Diamanti‐Kandarakis
出处
期刊:Human Reproduction
[Oxford University Press]
日期:2006-11-10
卷期号:22 (2): 317-322
被引量:108
标识
DOI:10.1093/humrep/del407
摘要
In the chronic treatment of polycystic ovary syndrome (PCOS), oral contraceptive pills (OCPs) are commonly used to induce regular menses, protect the endometrium and ameliorate androgenic symptoms. However, the long-term safety of OCP use in PCOS has not been established, and the literature reveals conflicting data concerning the metabolic effects of OCPs in this patient population, with outcomes ranging from improvement of glucose tolerance to the development of frank diabetes. This article presents new perspectives and a unifying hypothesis concerning the effects of OCPs on carbohydrate metabolism in PCOS and attempts to explain the divergent findings in published reports.
科研通智能强力驱动
Strongly Powered by AbleSci AI